DB
CRVO icon

Danske Bank’s CervoMed CRVO Stock Holding History

Danske Bank’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Hold
1
– – ﹤0.01% 1113
2025
Q4 		$8 Hold
1
– – ﹤0.01% 1487
2025
Q3 		$8 Hold
1
– – ﹤0.01% 1423
2025
Q2 		$6 Hold
1
– – ﹤0.01% 1473
2025
Q1 		$9 Hold
1
– – ﹤0.01% 1320
2024
Q4 		$2 Hold
1
– – ﹤0.01% 1378
2024
Q3 		$15 Buy
+1
New +$15 ﹤0.01% 1512

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Danske Bank's CRVO Position: Q1 2026 in Review

Danske Bank held its CervoMed (CRVO) position steady in Q1 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Danske Bank first reported a position in CRVO in Q3 2024 and has held it in 7 quarters since. The position peaked at $15 in Q3 2024. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Danske Bank held 1 share of CervoMed worth $4 as of Q1 2026.
  • Danske Bank left its CervoMed share count unchanged in Q1 2026.
  • CervoMed made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1113 holding.
  • Danske Bank first reported a position in CervoMed in Q3 2024 and has held it in 7 quarters since.
  • Danske Bank's CervoMed position peaked at $15 in Q3 2024.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.